Polly A. Murphy, Director at Atea Pharmaceuticals, Inc. (AVIR), bought 12,000 shares at $8.57 ($103K) on 2021-12-20, disclosed to the SEC on 2021-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CELC | BUY | 2022-11-23 | $48K | — | Filing → |